SANGIORGI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 44.109
AS - Asia 5.628
EU - Europa 3.389
SA - Sud America 838
AF - Africa 71
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 15
Totale 54.066
Nazione #
US - Stati Uniti d'America 43.965
SG - Singapore 2.736
CN - Cina 1.109
BR - Brasile 710
HK - Hong Kong 647
RU - Federazione Russa 617
UA - Ucraina 535
IT - Italia 495
IE - Irlanda 461
VN - Vietnam 417
DE - Germania 387
FR - Francia 238
GB - Regno Unito 208
JP - Giappone 162
FI - Finlandia 149
BD - Bangladesh 128
KR - Corea 124
SE - Svezia 101
IN - India 89
CA - Canada 79
PL - Polonia 48
AR - Argentina 40
NL - Olanda 40
ID - Indonesia 36
MX - Messico 36
IQ - Iraq 31
AT - Austria 25
TR - Turchia 25
ZA - Sudafrica 21
ES - Italia 20
EC - Ecuador 19
VE - Venezuela 19
PK - Pakistan 18
MY - Malesia 15
MA - Marocco 13
CO - Colombia 12
EU - Europa 12
AU - Australia 11
SA - Arabia Saudita 11
UZ - Uzbekistan 11
PE - Perù 10
PH - Filippine 9
PY - Paraguay 9
BE - Belgio 8
CH - Svizzera 8
CL - Cile 8
RO - Romania 8
TH - Thailandia 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
IL - Israele 7
LT - Lituania 7
TN - Tunisia 7
UY - Uruguay 7
JM - Giamaica 6
KE - Kenya 6
KG - Kirghizistan 6
GR - Grecia 5
IR - Iran 5
BG - Bulgaria 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
GT - Guatemala 4
NZ - Nuova Zelanda 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
CR - Costa Rica 3
HU - Ungheria 3
JO - Giordania 3
KZ - Kazakistan 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
RS - Serbia 3
SI - Slovenia 3
TW - Taiwan 3
A1 - Anonimo 2
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GA - Gabon 2
LV - Lettonia 2
ML - Mali 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
GD - Grenada 1
HN - Honduras 1
IM - Isola di Man 1
Totale 54.053
Città #
Woodbridge 11.906
Houston 11.401
Wilmington 11.283
Singapore 1.242
Fairfield 1.164
Ann Arbor 825
San Jose 759
Ashburn 737
Hong Kong 641
Seattle 493
Jacksonville 489
Beijing 470
Chandler 454
Dublin 443
Cambridge 387
Medford 360
The Dalles 231
Dearborn 196
Santa Clara 195
Council Bluffs 173
Lawrence 167
Los Angeles 158
New York 145
Ho Chi Minh City 143
Lauterbourg 141
Tokyo 137
Moscow 108
Rome 105
Hanoi 96
Buffalo 95
San Diego 91
São Paulo 69
Zhengzhou 54
Milan 53
Chicago 49
Dallas 49
Redondo Beach 48
Menlo Park 46
Mülheim 46
Helsinki 35
North Bergen 33
Denver 32
London 32
Phoenix 30
Guangzhou 29
Norwalk 29
Shanghai 29
Orem 28
Nuremberg 26
Hangzhou 25
Hefei 25
Verona 25
Warsaw 25
Redwood City 23
Toronto 23
Montreal 22
University Park 22
Kraków 21
Naples 19
Brooklyn 18
Chennai 18
Da Nang 18
Stockholm 18
Atlanta 17
Belo Horizonte 17
Frankfurt am Main 16
Nanjing 16
Rio de Janeiro 16
Curitiba 15
Detroit 15
Mountain View 15
Brasília 14
Jakarta 14
Mexico City 14
Vienna 14
Hyderabad 13
Manchester 13
Poplar 13
Salvador 13
Seoul 13
Baghdad 12
Porto Alegre 12
Kuala Lumpur 11
Mumbai 11
Campinas 10
Dhaka 10
Haiphong 10
Kunming 10
San Francisco 10
Shenzhen 10
Boston 9
Cangzhou 9
Istanbul 9
Las Vegas 9
Quảng Ngãi 9
Amsterdam 8
Ankara 8
Boardman 8
Bologna 8
Brescia 8
Totale 46.693
Nome #
Novel application of Angiojet rheolytic thrombectomy for massive thrombosis of the native aortic valve and Jarvick 2000 ventricular assist device in a patient with end-stage heart failure 571
A pathobiologic link between risk factors profile and morphological markers of carotid instability 502
Asymptomatic carotid plaque rupture with unexpected thrombosis over a non-canonical vulnerable lesion 498
Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: the INtegrilin plus STenting to Avoid myocardial Necrosis Trial 481
Intra-arterial lidocaine versus saline to reduce peri-procedural discomfort in patients undergoing percutaneous trans-radial or trans-ulnar coronary procedures 481
A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial 480
Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study 474
A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial 471
Role of inflammation in atherosclerosis 462
Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction 455
Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology 455
Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment 455
Age-related changes affecting atherosclerotic risk. Potential for pharmacological intervention 453
The Virtual histology in CaroTids Observational RegistrY (VICTORY) study: A European prospective registry to assess the feasibility and safety of intravascular ultrasound and virtual histology during carotid interventions 453
Hyperfibrinogenemia is associated with specific histocytological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks 447
The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment 443
Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial 441
Coronary artery apoptosis in experimental hypercholesterolemia 440
Extracellular proteases in atherosclerosis and restenosis 436
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design 435
To kiss or not to kiss? Impact of final kissing-balloon inflation on early and long-term results of percutaneous coronary intervention for bifurcation lesions 432
Insulin-like growth factor I and II preserve myocardial structure in postinfarct swine 430
Pioneer re-entry device for iliac chronic total occlusion: truly a paradigm shift 430
Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury 430
Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry 429
Arterial remodeling after experimental percutaneous injury is highly dependent on adventitial injury and histopathology 429
Endovascular repair of peripheral and visceral aneurysms with the Cardiatis multilayer flow modulator: one-year results from the Italian Multicenter Registry 428
Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome 426
Porcine model of stent thrombosis: platelets are the primary component of acute stent closure 426
Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke 425
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. 424
Transradial approach in the catheterization laboratory: Pros/cons and suggestions for successful implementation 423
Extracranial tthromotically active carotid plaque as a risk factor for ischemic stroke 422
Evaluating the safety of very short-term (10 days) dual antiplatelet therapy after Genous™ bio-engineered R stent™ implantation: the multicentre pilot GENOUS trial 422
Retrograde popliteal access as bail-out strategy for challenging occlusions of the superficial femoral artery: a multicenter registry 422
Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique 420
Artery size, neointima, and remodeling: time for some standards 418
Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction 418
Residual shunt after patent foramen ovale closure: preliminary results from Italian patent foramen ovale survey 414
Histo-morphometric evaluation of 2D characteristics and 3D sympathetic renal nerve distribution in hypertensive vs. normotensive patients 410
Mechanism of luminal patency of the self-expanding sideguard sidebranch stent: Evaluation by intravascular ultrasound and optical coherence tomography 409
Apoptosis. Basic concepts and implications in coronary artery disease 409
Experimental hypercholesterolemia induces apoptosis in the aortic valve 407
Cardiac amyloidosis detected by Tc-99m (V) DMSA myocardial uptake 407
Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia 407
Carotid plaque characterisation by IVUS-VH during carotid stenting: the "Eyes Wide Shut" between plaque morphology and symptoms 406
[Networks of care for ST-elevation myocardial infarction in Italy. Results of the RETE IMA WEB survey] 406
Treating chronic total occlusions using subintimal tracking and reentry: the STAR technique 406
[Unstable carotid plaque: biochemical and cellular marker of vulnerability] 403
Sex-related differences in carotid plaque features and inflammation 403
Are propensity scores really superior to standard multivariable analysis? 399
Treatment of superficial and profunda femoral artery bifurcation lesions: still a procedure only for surgeons? 399
Antegrade access: choose the right operator and the right patient 398
Early and long-term outlook of percutaneous coronary intervention for bifurcation lesions in young patients 395
Capture and repositioning of third-generation migrated abdominal endovascular graft by bilateral femoral wire externalization and pulling by "horse-riding" technique followed by balloon EVG stabilization 394
[Basic training in cardiology: theory and reality] 393
null 390
Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence 390
First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes 389
Upregulation of pregnancy-associated plasma protein in the inflammatory cells of carotid atherosclerotic plaques: A new marker of carotid plaque destabilization? 386
Repetita iuvant (repeating helps): why another paper on a new stent is important 386
Drug-eluting balloons for peripheral artery disease: a meta-analysis of 7 randomized clinical trials and 643 patients 386
Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events 385
Reduction of scatter radiation during transradial percutaneous coronary angiography: a randomized trial using a lead-free radiation shield 384
Intravascular ultrasound comparison of the self-expanding Sideguard stent in the side branch versus a balloon-expandable stent in the main vessel to assess mechanisms of acute lumen gain in bifurcation lesions 383
Right versus left radial artery access for coronary procedures: An international collaborative systematic review and meta-analysis including 5 randomized trials and 3210 patients 381
Percutaneous left main coronary disease treatment without on-site surgery back-up in patients with acute coronary syndromes: immediate and 2-year outcomes 381
Pathology of acute and chronic coronary stenting in humans 380
Results and follow-up after implantation of four or more sirolimus-eluting stents in the same patient 380
Importance and limits of pre-hospital electrocardiogram in patients with ST elevation myocardial infarction undergoing percutaneous coronary angioplasty 380
Chapter 2: Pathobiology of the asymptomatic atherosclerotic carotid plaque 379
Histologic correlates of angiographic chronic total coronary artery occlusions: influence of occlusion duration on neovascular channel patterns and intimal plaque composition 378
Devices for infrainguinal endovascular therapy: menu à la carte or table d'hôte? 377
Fibrin-film stenting in a porcine coronary injury model: efficacy and safety compared with uncoated stents 377
How should I treat a long and huge coronary pseudoaneurysm after spontaneous coronary artery dissection? 374
Evidence of a topographical link between unstable carotid plaques and luminal stenosis: Can we better stratify asymptomatic patients with significant plaque burden? 373
Inflammation and atherosclerosis: evolving concepts leading the development of new therapies 371
Pregnancy-associated plasma protein: a new marker of carotid plaque vulnerability? 370
From the abluminal biodegradable polymer stent to the polymer free stent. Clinical evidence 370
Does the target vessel impact on results of percutaneous coronary intervention for bifurcation lesions? Insights from the I-BIGIS registry 369
Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque. 369
Plasma levels of metalloproteinases-9 and -2 in the acute and subacute phases of type A and type B aortic dissection 368
Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses 365
Experimental hypercholesterolemia induces ultrastructural changes in the internal elastic lamina of porcine coronary arteries 363
In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent 363
Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) score 361
Transradial versus transfemoral intervention for acute myocardial infarction: a propensity score-adjusted and -matched analysis from the REAL (REgistro regionale AngiopLastiche dell'Emilia-Romagna) multicenter registry 361
Commentary: drug-eluting balloons for carotid in-stent restenosis: can this technology deliver the goods? 361
Long-term outcome of percutaneous exclusion of huge saphenous vein graft aneurysms using peripheral covered-stents as alternative to surgical repair 359
Outcome of patients on oral anticoagulation undergoing coronary artery stenting: data from discharge to 12 months in the Warfarin and Coronary Stenting (WAR-STENT) Registry 358
Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction 357
Commentary: using vascular closure devices outside the operating room: no reason for homesickness! 357
Has gender a significant impact on carotid plaque instability and inflammation? Evidence from a 457-patient clinicopathologic study 353
Chapter 7: From Coronaries to Carotids: Shifting the Paradigm of Plaque Vulnerability 352
Chapter 2. Atherogenesis and Inflammation 351
Resolute italian study in all comers: Immediate and One-Year Outcomes 350
Radial versus femoral approach comparison in percutaneous coronary intervention with intraaortic balloon pump support: the RADIAL PUMP UP registry 339
Increased plasma levels of metalloproteinase-9 and-2 in acute and subacute aortic dissection 335
New biochemical markers of aortic dissection 332
Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions 329
Totale 40.454
Categoria #
all - tutte 130.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.847


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 0 0 0 0 0 0 52
2021/20221.667 42 275 160 73 88 78 96 83 82 73 138 479
2022/20231.422 207 99 38 138 105 383 154 73 82 5 92 46
2023/2024394 40 19 26 19 44 54 28 9 27 13 6 109
2024/20254.140 99 855 317 178 91 145 323 343 461 490 437 401
2025/20266.641 453 409 818 627 563 213 687 895 728 603 434 211
Totale 54.552